2009 Annual Report: Shandong Pharmaceutical Glass

Date: 25 March 2010
Source: Tradingmarkets.com
The following is a table showing the main business indicators for 2009 of Shanghai-listed Shandong Pharmaceutical Glass Co.

Ltd. (600529.SH): 2009/adjusted 2008/adjusted Earnings per share (yuan) 0.56/0.57 0.53/0.47 Net assets per share (yuan) 6.18 5.65 Return on net assets (pct) 9.5 9.77 Net cash flow (yuan) 0.97 0.36 Main operating turnover (million yuan) 1242.1585 1158.2921 Net profit attributable to group (million yuan) 144.3619(147.8822) 135.1625 Distribution plan 0.1 yuan cash dividend per share (Tax included)
Read more here.

600450 2009 Annual Report: Shandong Pharmaceutical Glass glassonweb.com
Date: 25 March 2010
Source: Tradingmarkets.com

See more news about:

See more from these topics:

Others also read

Kohn Pedersen Fox (KPF) proudly supported the opening of MGM COTAI on Tuesday, February 13 2018. The resort is the latest addition to the MGM portfolio in Macau.
With various features including light weight, thin thickness, clear transparency, high safety, and extensive use in many aspects of building construction without regional limitation, LandVac has been well received by consumers.
As the launch pad for new products and technologies on window, door and facade in China, the 24th Windoor Expo will take place in Guangzhou from March 11 to March 13, 2018.
Considering the use of energy-saving glass as the determinant of a building’s power conservation, vacuum insulated glass currently offers the most outstanding performance in energy-saving. Among them, LandVac® is one of the best.
Recently, LandGlass is successfully selected into the list of the Innovative Large Enterprises of the City by the department of science and technology in Luoyang.
Glass expertise in oversize formats.

From industry

No. 160 Yichuan Rd.,
Jiaonan Shi
Qingdao Shi
Shandong Sheng, 266000

Add new comment